Edge
Natural health product licensed in Canada
- Licence holder
- Plexus Canada Limited Partnership dba Plexus Worldwide
- NPN or DIN-HM
- 80076784
- Status
- Inactive licence
- Licence date
- 18 April 2017
- Revision date
- 17 May 2019
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| 1,3,7-triméthylxanthine Source : Coffea arabica graine | 90 milligramme | Not calculated |
| 7,9-Dihydro-1,3,7,9-tétraméthyl-1H-purine-2,6,8(3H)-trione Source : Théacrine | 125 milligramme | Not calculated |
| L-théanine Source : L-Théanine | 100 milligramme | Not calculated |
Non-medicinal ingredients
Hypromellose, Cellulose microcristalline, Dioxyde de silicium, Stéarate de magnésium, Silicate de calcium
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 1 Capsule | 1 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
Helps to temporarily increase energy and to reduce fatigue. Helps support cognitive performance. Helps to temporarily improve sustained attention. Helps to temporarily improve sustained attention in 60 minutes. Helps to temporarily support sustained attention. Helps to temporarily improve mental alertness. Helps to temporarily promote mental focus.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Contre-indications
Hypersensitivity/allergy is known to occur, in which case, discontinue use.
- Précautions et mises en garde
Consult a health care practitioner prior to use if you are taking lithium. Consult a health care practitioner prior to use if you have high blood pressure, glaucoma, and/or detrusor instability (overactive bladder syndrome). Consumption with natural health products (e.g. bitter orange extract, synephrine, octopamine, ephedra) or other drugs (e.g. ephedrine) which increase blood pressure is not recommended. Consumption with other caffeine-containing products (e.g. medications, coffee, tea, colas, cocoa, guarana, maté) is not recommended. This product is not intended as a substitute for sleep.
- Effets indésirables connus
Caffeine may cause anxiety, tachycardia (rapid heart rate), palpitations, insomnia, restlessness, nervousness, tremor and headache.
Source
Official Health Canada record, licence 80076784
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
List recorded in 2019. Photograph the packaging to check whether it has changed.
Has the product changed? Photograph the packaging.